Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making

被引:8
|
作者
Sola-Morales, Oriol [1 ]
Siguroardottir, Katla [1 ]
Akehurst, Ron [2 ]
Murphy, Linda A. [2 ]
Mestre-Ferrandiz, Jorge
Cunningham, David
de Pouvourville, Gerard [3 ]
机构
[1] Fdn HiTT, Barcelona, Spain
[2] Lumanity Inc, Sheffield, England
[3] ESSEC Business Sch, Cergy Pontoise, France
关键词
data governance; real-world data; real-world evidence; BIG DATA; TASK-FORCE; HEALTH;
D O I
10.1016/j.jval.2023.02.012
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Real-world data (RWD) and real-world evidence (RWE) can provide extensive information on healthcare for use in health technology assessment and decision making. Nevertheless, there is a lack of consensus surrounding the appropriate data governance (DG) practices for RWD/RWE. Data sharing is also a large concern, especially considering evolving data protection regulations. Our objective is to propose recommendations for international standards of evaluating the acceptability of RWD governance practices. Methods: After reviewing the literature, we created a checklist targeting DG practices for RWD/RWE. We then carried out a 3-round Delphi panel, including European policy makers, health technology assessment experts, and hospital managers. The consensus for each statement was measured and the checklist adjusted accordingly. Results: The literature review identified the main topics regarding RWD/RWE DG practices: data privacy and security, data management and linkage, data access management, and the generation and use of RWE. Members of the Delphi panel (21 experts/25 invited) were presented a total of 24 statements related to each of the topics. Experts demonstrated a progressive level of consensus and importance ratings in all topics and to most statements. We suggest a refined checklist in which the statements rated less important or with less consensus have been removed. Conclusions: This study suggests how the DG of RWD/RWE could be qualitatively evaluated. We propose checklists that could be used by all RWD/RWE users to help ensure the quality and integrity of RWD/RWE governance and complement data protection law.
引用
收藏
页码:32 / 42
页数:11
相关论文
共 50 条
  • [1] Contributions of Real-World Evidence and Real-World Data to Decision-Making in the Management of Soft Tissue Sarcomas
    Demetri, George D.
    Stacchiotti, Silvia
    ONCOLOGY, 2021, 99 (SUPPL 1) : 3 - 7
  • [2] What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward
    Kc, Sarin
    Lin, Lydia Wenxin
    Bayani, Diana Beatriz Samson
    Zemlyanska, Yaroslava
    Adler, Amanda
    Ahn, Jeonghoon
    Chan, Kelvin
    Choiphel, Dechen
    Genuino-Marfori, Anne Julienne
    Kearney, Brendon
    Liu, Yuehua
    Nakamura, Ryota
    Pearce, Fiona
    Prinja, Shankar
    Pwu, Raoh-Fang
    Shafie, Arsul Akmal
    Sui, Binyan
    Suwantika, Auliya
    Tunis, Sean
    Wu, Hui-Min
    Zalcberg, John
    Zhao, Kun
    Isaranuwatchai, Wanrudee
    Teerawattananon, Yot
    Wee, Hwee-Lin
    INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2023, 12
  • [3] Data Science Methods for Real-World Evidence Generation in Real-World Data
    Liu, Fang
    ANNUAL REVIEW OF BIOMEDICAL DATA SCIENCE, 2024, 7 : 201 - 224
  • [4] Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
    Cave, Alison
    Kurz, Xavier
    Arlett, Peter
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) : 36 - 39
  • [5] Real-World Data and Real-World Evidence in Regulatory Decision Making: Report Summary From the Council for International Organizations of Medical Sciences (CIOMS) Working Group XIII
    Hennessy, Sean
    Atsuta, Yoshiko
    Hill, Sanna
    Raego, Lembit
    Juhaeri, Juhaeri
    Council Int Org Med Sci CIOMS Working Grp X, III
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2025, 34 (03)
  • [6] Real-world evidence to support health technology assessment and payer decision making: is it now or never?
    Murphy, Linda A.
    Akehurst, Ron
    Cunningham, David
    de Pouvourville, Gerard
    Sola-Morales, Oriol
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2025, 41 (01)
  • [7] Impact of Real-World Data on Market Authorization, Reimbursement Decision & Price Negotiation
    Pulini, Alfredo Aram
    Caetano, Gabriela Martins
    Clautiaux, Henri
    Vergeron, Laure
    Pitts, Peter J.
    Katz, Gregory
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (01) : 228 - 238
  • [8] Big data and real-world data-based medicine in the management of hypertension
    Mihoko Okada
    Hypertension Research, 2021, 44 : 147 - 153
  • [9] Big data and real-world data-based medicine in the management of hypertension
    Okada, Mihoko
    HYPERTENSION RESEARCH, 2021, 44 (02) : 147 - 153
  • [10] Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms
    Burcu, Mehmet
    Dreyer, Nancy A.
    Franklin, Jessica M.
    Blum, Michael D.
    Critchlow, Cathy W.
    Perfetto, Eleanor M.
    Zhou, Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1228 - 1235